| Line Item | 2025-06-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.4M | -46.4% | -11.6% |
| Cost of Revenue | $3.1M | -36.8% | -20.1% |
| Gross Profit | $2.3M | -55.5% | +3.3% |
| R&D Expense | $0 | — | — |
| SG&A Expense | $2.1M | -52.8% | -15.4% |
| Operating Income | -$167K | -150.5% | +85.1% |
| Pre-tax Income | -$425K |
| Line Item | 2025-06-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.3M | -91.4% | -92.7% |
| Accounts Receivable | $91K | +119.8% | +249.3% |
| Current Assets | $26.5M | -32.8% | -36.0% |
| Total Assets | $31.7M | -31.0% | -33.0% |
| Current Liabilities | $22.4M | -23.8% | -31.3% |
| Total Liabilities |
| Line Item | 2025-06-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.9M | -869.8% | — |
| Investing Cash Flow | $1.4M | +69.8% | — |
| Financing Cash Flow | -$5.2M | -608.7% | — |
| +59.3% |
| Net Income | -$425K | -241.3% | +59.3% |
| EPS (Basic) | $0.00 | — | — |
| EPS (Diluted) | $0.00 | — | — |
| $23.4M |
| -22.5% |
| -29.3% |
| Stockholders' Equity | $8.2M | -47.4% | -41.9% |